Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukemia: therapeutic targeting of stem cells
Cindy M. Pabon, Hussein A. Abbas, Marina Konopleva
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 6, pp. 547-556
Closed Access | Times Cited: 13

Showing 13 citing articles:

BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL
Karin Bauer, Alexander W. Hauswirth, Karoline V. Gleixner, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 9, pp. 1721-1731
Open Access | Times Cited: 6
Therapeutic Hurdles in Acute Myeloid Leukemia: Leukemic Stem Cells, Inflammation and Immune Dysfunction
Bofei Wang, Patrick K. Reville, Hussein A. Abbas
Current Opinion in Pharmacology (2025), pp. 102526-102526
Closed Access
Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia
Atefe Rahmati, Alireza Mafi, Firooze Soleymani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Functions and clinical significance of circular RNAs in acute myeloid leukemia
Min Zhou, Xianling Gao, Xin Zheng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Single-cell transcriptomics reveals heterogeneity and prognostic markers of myeloid precursor cells in acute myeloid leukemia
Guanghua He, Lai Jiang, Xuancheng Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
miRNA-126 as a Biomarker for Cancer Stem Cells: Role in Chemotherapy Resistance in Iraqi Patients with Acute Myeloid Leukemia
Noorhan Sabih Al-Maliki, Zahraa K. Zedan
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 195-199
Open Access | Times Cited: 1
Finding potential targets in cell-based immunotherapy for handling the challenges of acute myeloid leukemia
Amir Hossein Kheirkhah, S Habibi, Mohammad Hasan Yousefi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
Lindsey Murphy, Amanda Winters
(2023)
Open Access | Times Cited: 3
Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia
Dongyue Zhang, Xiaoxi Cui, Yifei Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 2
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells
Lindsey Murphy, Amanda Winters
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3248-3248
Open Access | Times Cited: 2
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias
Sisi Li, Zhu‐Jun Wang, Xiaoping Guo, et al.
Neoplasia (2024) Vol. 59, pp. 101084-101084
Closed Access
Casticin inhibits the hedgehog signaling and leads to apoptosis in AML stem-like KG1a and mature KG1 cells
Tuğba Erkmen, Gizem Gülfidan, Halil Ateş, et al.
Turkish Journal of Biochemistry (2024)
Closed Access
Novel Therapeutics Targeting Cancer Stem Cell Surface Markers
Sujani Madhurika Kodagoda Gamage, Chamath D. Ranaweera, Kalana Maduwage, et al.
(2023), pp. 167-198
Closed Access | Times Cited: 1
Page 1

Scroll to top